Xiaobo Li

8.3k total citations
279 papers, 5.1k citations indexed

About

Xiaobo Li is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Xiaobo Li has authored 279 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 41 papers in Pharmacology and 41 papers in Complementary and alternative medicine. Recurrent topics in Xiaobo Li's work include Pharmacological Effects of Natural Compounds (31 papers), Ginseng Biological Effects and Applications (29 papers) and Natural product bioactivities and synthesis (29 papers). Xiaobo Li is often cited by papers focused on Pharmacological Effects of Natural Compounds (31 papers), Ginseng Biological Effects and Applications (29 papers) and Natural product bioactivities and synthesis (29 papers). Xiaobo Li collaborates with scholars based in China, United States and Italy. Xiaobo Li's co-authors include Ying Peng, Mengyue Wang, Zhi‐Zheng Ge, Guisheng Zhou, Chongsheng Peng, Lijuan Zhao, Jing‐Yuan Fang, Yulong Zhang, Haiming Shi and Ping Ma and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaobo Li

270 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo Li China 35 2.3k 573 561 544 525 279 5.1k
Fermín Sánchez de Medina Spain 41 2.6k 1.1× 703 1.2× 494 0.9× 464 0.9× 692 1.3× 126 5.7k
Han Geuk Seo South Korea 48 3.3k 1.4× 968 1.7× 534 1.0× 376 0.7× 486 0.9× 214 7.1k
Joen‐Rong Sheu Taiwan 43 2.1k 0.9× 436 0.8× 534 1.0× 435 0.8× 405 0.8× 233 6.0k
Elźbieta Skrzydlewska Poland 46 2.1k 0.9× 611 1.1× 616 1.1× 287 0.5× 253 0.5× 281 7.4k
Jianping Chen China 41 2.5k 1.1× 329 0.6× 519 0.9× 524 1.0× 266 0.5× 231 5.3k
Wenhua Li China 43 2.9k 1.3× 462 0.8× 612 1.1× 761 1.4× 605 1.2× 328 7.5k
Yinglun Li China 28 1.6k 0.7× 342 0.6× 490 0.9× 352 0.6× 309 0.6× 65 5.2k
Yue Dai China 43 2.3k 1.0× 334 0.6× 432 0.8× 528 1.0× 301 0.6× 185 5.2k
Shannon Reagan‐Shaw United States 21 2.8k 1.2× 934 1.6× 426 0.8× 786 1.4× 449 0.9× 21 7.0k
Minakshi Nihal United States 27 2.6k 1.1× 984 1.7× 434 0.8× 812 1.5× 436 0.8× 49 7.5k

Countries citing papers authored by Xiaobo Li

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Li more than expected).

Fields of papers citing papers by Xiaobo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Li. The network helps show where Xiaobo Li may publish in the future.

Co-authorship network of co-authors of Xiaobo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Li. A scholar is included among the top collaborators of Xiaobo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Li. Xiaobo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xueli, et al.. (2025). Identification of key differential compounds in different quality grades of base liquor during the production of Jiang-flavored baijiu. Food Chemistry X. 26. 102331–102331. 4 indexed citations
2.
Shi, Jiaqi, Yingying Zhang, Na Zhao, et al.. (2025). Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy. The Innovation. 7(1). 101074–101074. 3 indexed citations
4.
Relucenti, Michela, Claudia Tito, Paolo Mercantini, et al.. (2024). High WTAP expression level as a promising biomarker for poor prognosis in colorectal cancer: a pilot study. European Journal of Histochemistry. 68(4). 1 indexed citations
5.
Li, Xiaobo, Yunqian Guan, Danni Chen, et al.. (2024). Immune Cells Promote BDNF Expression by Infiltrated Macrophages via Interleukin 4 in the Cerebral Ischemia of Male Rats. Journal of Neuroscience Research. 102(9). e25379–e25379. 1 indexed citations
7.
Ma, Chong & Xiaobo Li. (2021). Multi-modal brain tumor image segmentation based on improved U-net model. 2021 IEEE 5th Information Technology,Networking,Electronic and Automation Control Conference (ITNEC). 706–710. 2 indexed citations
8.
Miglietta, Selenia, Raffaele Borghini, Michela Relucenti, et al.. (2021). New Insights into Intestinal Permeability in Irritable Bowel Syndrome-Like Disorders: Histological and Ultrastructural Findings of Duodenal Biopsies. Cells. 10(10). 2593–2593. 14 indexed citations
9.
10.
Li, Xiaobo, Yunqian Guan, Haiqiang Zou, et al.. (2020). Peripheral Circulation and Astrocytes Contribute to the MSC-Mediated Increase in IGF-1 Levels in the Infarct Cortex in a dMCAO Rat Model. Stem Cells International. 2020. 1–13. 6 indexed citations
11.
Zhang, Qingwei, Xintian Zhang, Chao‐Tao Tang, et al.. (2019). EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β‐catenin pathway. Molecular Carcinogenesis. 58(6). 967–979. 17 indexed citations
13.
Zhao, Lijuan, Hong‐Xiang Lou, Ying Peng, et al.. (2019). Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 66(3). 526–537. 175 indexed citations
15.
Wang, Mengyue, Renjie Xu, Ying Peng, & Xiaobo Li. (2018). Metabolism Analysis of Alantolactone and Isoalantolactone in Rats by Oral Administration. Journal of Chemistry. 2018. 1–7. 4 indexed citations
16.
Du, Wei, Xing Xu, Qing Niu, et al.. (2017). Spi-B–Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors. Cancer Research. 77(18). 4809–4822. 28 indexed citations
17.
Li, Xiaobo, Yueming Zhu, Yan Zeng, Tong‐Cun Zhang, & Yuanxia Sun. (2013). Overexpression of D-psicose 3-epimerase from <em>Clostridium cellulolyticum</em> H10 in <em>Bacillus subtilis</em> and its Prospect for D-psicose Production. Advance Journal of Food Science and Technology. 5(3). 264–269. 6 indexed citations
18.
Wu, Zhuo, Xiaobo Li, Yanyan Zeng, et al.. (2010). In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA. Basic & Clinical Pharmacology & Toxicology. 108(3). 177–184. 17 indexed citations
19.
Kong, Jing, et al.. (2006). A molecular Biological Method for Screening and Evaluating the Traditional Chinese Medicine Used in Pi-deficiency Therapy Involving Intestinal microflora. 亚洲传统医药. 1(1). 1–6. 4 indexed citations
20.
Li, Xiaobo, et al.. (1997). Pharmacognostical studies on the Chinese crude drug 'Shengma' (Part II): 'Shengma' derived from genus Cimicifuga plants. Natural medicines = 生薬學雜誌. 51(2). 148–161. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026